EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Astragaloside IV Alleviates Ulcerative Colitis Progression by Inhibiting WDR5 ‐Mediated ENO1 H3K4me3 Modification

Su-Xiao Wu, Zi-Lan Chen, Xiao-Hong Wang, Jie Gu iD

The Kaohsiung Journal of Medical Sciences · 2025-11 · 41 (11)

DOI: 10.1002/kjm2.70064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, online erschienen am 30.06.2025. Verfasst von Su-Xiao Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou, Jiangsu, People's Republic of China. Hauptthemen laut MEDLINE: Saponins, Triterpenes, Colitis, Ulcerative, DNA-Binding Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guiding Project of Suzhou Science and Technology Development Plan for 2021 (Medical and Health Technology Innovation - Applied Basic Research [Second Batch]).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) has become a prevalent global health concern. This study scrutinized the influence of Astragaloside IV (ASI) on DSS‐induced UC, with particular emphasis on the role of WDR5 in mediating ENO1 expression. The therapeutic efficacy of ASI was assessed in a mouse model of UC by evaluating disease activity index, pathology, colon length, and inflammatory factor contents. Through bioinformatics analysis, the UC‐related differentially expressed genes were predicted using the GSE38713 database and intersected with the lists of ASI targets and transcription factors, and the protein–protein network was constructed to screen the key target transcription factors. ASI inhibited the shortening of colon length, reduced histological damage scores, ameliorated pathology, and the overproduction of pro‐inflammatory cytokines. After ASI treatment, DSS‐stimulated human NCM460 cells showed increased cell viability, decreased levels of pro‐inflammatory cytokines and cleaved‐Caspase‐3, and enhanced ZO‐1 and claudin‐3 expression. WDR5 was a target of ASI in UC, and overexpression of WDR5 compromised the effects of ASI. WDR5 promoted the H3K4me3 modification of the ENO1 promoter and thereby regulated ENO1 transcriptional activation. Silencing of ENO1, again, repressed NCM460 cell apoptosis and alleviated UC‐like symptoms in mice. In conclusion, ASI mitigated UC by inhibiting WDR5 and reducing H3K4me3‐mediated ENO1 activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SaponinsTriterpenesColitis, UlcerativeDNA-Binding ProteinsPhosphopyruvate HydrataseHistonesTumor Suppressor ProteinsIntracellular Signaling Peptides and ProteinsAnimalsHumansMiceDisease Models, AnimalMaleMice, Inbred C57BLDisease ProgressionPromoter Regions, GeneticCell LineCytokinesBiomarkers, Tumor

Stichwörter der Autor:innen

Astragaloside IVENO1H3K4me3WDR5ulcerative colitis

Substanzen

SaponinsTriterpenesastragaloside ADNA-Binding ProteinsPhosphopyruvate HydrataseHistonesTumor Suppressor ProteinsENO1 protein, humanIntracellular Signaling Peptides and ProteinsCytokines

Autor:innen und Institutionen

  • Department of Gastroenterology, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou, Jiangsu, People's Republic of China.

ORCID-Profile: Jie Gu

Förderung

  • Guiding Project of Suzhou Science and Technology Development Plan for 2021 (Medical and Health Technology Innovation - Applied Basic Research [Second Batch])

Zitieren

APA

Wu, S. X., Chen, Z. L., Wang, X. H., & Gu, J. (2025). Astragaloside IV Alleviates Ulcerative Colitis Progression by Inhibiting WDR5 ‐Mediated ENO1 H3K4me3 Modification. The Kaohsiung Journal of Medical Sciences, 41(11). https://doi.org/10.1002/kjm2.70064

Vancouver

Wu SX, Chen ZL, Wang XH, Gu J. Astragaloside IV Alleviates Ulcerative Colitis Progression by Inhibiting WDR5 ‐Mediated ENO1 H3K4me3 Modification. The Kaohsiung Journal of Medical Sciences. 2025;41(11). doi:10.1002/kjm2.70064

BibTeX
@article{Wu2025,
  author = {Wu, Su-Xiao and Chen, Zi-Lan and Wang, Xiao-Hong and Gu, Jie},
  title = {Astragaloside IV Alleviates Ulcerative Colitis Progression by Inhibiting WDR5 ‐Mediated ENO1 H3K4me3 Modification},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2025},
  volume = {41},
  number = {11},
  doi = {10.1002/kjm2.70064}
}
Kostenlos starten →